Résultat(s) 121 - 140 résultats de 2 426 pour la requête 'harm is (((((remove. OR resolvedddsssdss.) OR resolved.) OR involves.) OR involved.) OR resolve.)', Temps de recherche: 0,47s Affiner les résultats
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128
  9. 129
  10. 130

    Trends in the valuation of injury involving the face: an analysis on trial in Rio Grande do Sul, Brazil par Gabriela Cauduro da ROSA (4647883)

    Publié 2020
    “…To measure the damage, the assessment of the bodily harm is required. Objective To analyze jurisprudential characteristics involving the valuation of the damage related to facial trauma, highlighting trends Methods It was analyzed secondary data, which are public domain, of the precedents of the Court of Justice of Rio Grande do Sul State from 2008 to 2016. …”
  11. 131
  12. 132
  13. 133

    Table_3_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx par Daniele Mercatelli (6031271)

    Publié 2020
    “…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
  14. 134

    Table_1_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx par Daniele Mercatelli (6031271)

    Publié 2020
    “…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
  15. 135

    Table_2_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx par Daniele Mercatelli (6031271)

    Publié 2020
    “…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
  16. 136
  17. 137
  18. 138
  19. 139

    Patient Involvement in Preparing Clinical Research Peer-Reviewed Publications or Results Summaries: A Systematic Review par Karen L. Woolley (4910764)

    Publié 2018
    “…<div><b>Objective</b></div><div>Although patient involvement in results reporting is being encouraged, relevant evidence must be assessed before developing best practice guidelines. …”
  20. 140